Travoprost/brinzolamide ophthalmic suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Travoprost/brinzolamide ophthalmic suspension, covering 2015-12-29 to 2015-12-29. Get the full timeline:
Most recent: Clinical Trial Update: 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]